MaxWell Biosystems at iForum 2017 in London

On September 28, 2017, MaxWell Biosystems’ VP of Scientific Affairs, Michele Fiscella, travelled to London to meet with stem cell researchers from academia, and the pharma and biotech industries. Michele presented results from using the MaxOne platform with induced pluripotent stem cells (iPSCs) in a presentation titled, “High-resolution microelectrode array platform for biomarker discovery and novel functional assays with human iPSC-derived neurons.”   After presenting promising results and receiving a positive reception from researchers at iForum, Michele is excited about the potential for using MaxWell Biosystems’…

Read More

MaxWell Biosystems at ISSCR2017 Annual Meeting

MaxWell Biosystems had a great time at the ISSCR2017 Annual Meeting in Boston. The conference was held on the 14th to 17th of June at the Boston Convention and Exhibition Center. The ISSCR annual meeting brought together stem cell researchers from all over the world  aiming to create strong research networks and new opportunities to push forward the research about degenerative and rare diseases. One of the highlights of the meeting was the talk of Prof. Dr. Shinya Yamanaka, who received a Nobel Prize…

Read More

MaxWell Biosystems in Cambridge, UK

MaxWell Biosystems exhibited MaxOne with its newly developed data acquisition unit at the SelectBio Advances in Drug Discovery Conference in Hinxton, Cambridge, UK. It was an exciting meeting, attended by many researchers who are currently screening for efficacy and toxicity using iPS cell lines or developing enabling techniques and technologies for this. Progress in stem cell biology is revolutionizing drug discovery research now; the ability to grow and differentiate stem cell lines is providing a far more relevant model for…

Read More
Contacts








Mattenstrasse 26
4058 Basel, Switzerland

+41 61 551 10 70

+41 61 551 10 71

info@mxwbio.com